Search results
Results from the WOW.Com Content Network
By Sriparna Roy. (Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and ...
Website. unither .com. United Therapeutics Corporation is an American publicly traded biotechnology company [ 2] and public benefit corporation [ 3] listed on the NASDAQ under the symbol UTHR. [ 4][ 5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
The backing from the European Union drug watchdog's committee comes two days after Wegovy secured a similar nod from the UK regulator, while the U.S. Food and Drug Administration approved the drug ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
August 9, 2024 at 4:25 PM. (Reuters) - Humacyte said on Friday the U.S. health regulator has extended review of the company's implant that can act as a replacement for an injured or damaged blood ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary ...
Click here for in-depth analysis of the latest stock market news and events moving stock prices. Read the latest financial and business news from Yahoo Finance. Show comments. Advertisement ...